Kura Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	37.32	51.8	90.88	325.7	26.14	16.12	11.43	9.73	15.44
Short-Term Investments	386.64	386.18	427.29	307.83	210.76	162.87	81.71	58.07	70.3
Cash & Cash Equivalents	423.96	437.99	518.17	633.53	236.89	178.99	93.15	67.79	85.75
Cash Growth	-3.20%	-15.47%	-18.21%	167.44%	32.35%	92.16%	37.40%	-20.94%	-
Receivables	0	0	0	0	0	0.22	0.22	0.3	0.43
Other Current Assets	8.52	8.44	4.12	3.76	2.71	1.99	1.28	0.73	0.69
Total Current Assets	432.48	446.43	522.29	637.29	239.6	181.2	94.64	68.81	86.87
Property, Plant & Equipment	8.85	6.38	8.25	8.36	0.28	0	0.01	0.04	0.07
Other Long-Term Assets	7.6	3.5	3.52	1.57	2.09	1.18	1.2	0.97	0.32
Total Long-Term Assets	16.45	9.88	11.76	9.92	2.37	1.18	1.21	1.01	0.39
Total Assets	448.94	456.31	534.05	647.21	241.97	182.38	95.85	69.82	87.26
Accounts Payable	33.76	21.74	20.19	23.02	15.31	13.62	8.5	5.45	5.06
Current Debt	1.51	2.32	2.26	3	0.25	0	1.53	0	0
Total Current Liabilities	35.26	24.06	22.46	26.02	15.56	13.62	10.03	5.45	5.06
Long-Term Debt	15.69	11.71	4.61	9.89	7.25	7.5	5.57	7.32	0
Other Long-Term Liabilities	0.71	0.27	0.38	0.4	0.38	0.28	0.39	0.17	0.1
Total Long-Term Liabilities	16.4	11.97	4.99	10.28	7.63	7.78	5.96	7.49	0.1
Total Liabilities	51.66	36.03	27.44	36.31	23.19	21.39	15.99	12.95	5.16
Total Debt	17.2	14.02	6.88	12.89	7.5	7.5	7.1	7.32	0
Debt Growth	22.65%	103.99%	-46.66%	71.84%	-	5.66%	-3.09%	-	-
Retained Earnings	-721.44	-568.81	-432.97	-302.5	-212.88	-149.74	-89.29	-53.86	-26.3
Comprehensive Income	-1.27	-8.03	-1.79	0.05	0.33	-0.13	-0.05	-0.02	-0.09
Shareholders' Equity	397.27	420.28	506.61	610.91	218.78	160.99	79.87	56.88	82.1
Net Cash / Debt	406.76	423.96	511.3	620.64	229.39	171.49	86.05	60.47	85.75
Net Cash / Debt Growth	-4.06%	-17.08%	-17.62%	170.56%	33.77%	99.29%	42.31%	-29.48%	-
Net Cash Per Share	5.55	6.33	7.71	11.69	5.47	4.87	3.70	3.23	8.63
Working Capital	397.22	422.37	499.83	611.27	224.04	167.58	84.61	63.36	81.81
Book Value Per Share	5.42	6.27	7.63	11.51	5.22	4.58	3.44	3.04	8.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).